Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Sparks

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Alzheimer Research|August 12, 2008
Reduced risk of incident AD with elective statin use in a clinical trial cohortD Larry Sparks, Richard J Kryscio, Marwan N Sabbagh, et al.
Neuro-Degenerative Diseases|March 13, 2010
Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohortD Larry Sparks, Richard J Kryscio, Donald J Connor, et al.
American Journal of Neurodegenerative Disease|February 6, 2013
Tau is reduced in AD plasma and validation of employed ELISA methodsD Larry Sparks, Richard J Kryscio, Marwan N Sabbagh, et al.
Cleveland Clinic Journal of Medicine|June 11, 2008
Hippocampal volume change in the Alzheimer Disease Cholesterol-Lowering Treatment trialD Larry Sparks, Susan K Lemieux, Marc W Haut, et al.
Immunity|August 23, 2003
The T cell surface--how well do we know it?Edward J Evans, Lawrence Hene, Lisa M Sparks, et al.
The Journal of Biological Chemistry|June 29, 2006
Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48Edward J Evans, Mónica A A Castro, Ronan O'Brien, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Alzheimer Research|August 12, 2008
Reduced risk of incident AD with elective statin use in a clinical trial cohortD Larry Sparks, Richard J Kryscio, Marwan N Sabbagh, et al.
Neuro-Degenerative Diseases|March 13, 2010
Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohortD Larry Sparks, Richard J Kryscio, Donald J Connor, et al.
American Journal of Neurodegenerative Disease|February 6, 2013
Tau is reduced in AD plasma and validation of employed ELISA methodsD Larry Sparks, Richard J Kryscio, Marwan N Sabbagh, et al.
Cleveland Clinic Journal of Medicine|June 11, 2008
Hippocampal volume change in the Alzheimer Disease Cholesterol-Lowering Treatment trialD Larry Sparks, Susan K Lemieux, Marc W Haut, et al.
Immunity|August 23, 2003
The T cell surface--how well do we know it?Edward J Evans, Lawrence Hene, Lisa M Sparks, et al.
The Journal of Biological Chemistry|June 29, 2006
Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48Edward J Evans, Mónica A A Castro, Ronan O'Brien, et al.
Pageof 1